Vision Response to Dopamine Replacement
NCT01663935
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
OTHER
Sponsor class
Stopped
Lack of funding
Conditions
Albinism
Oculocutaneous Albinism
Interventions
DRUG:
Levodopa/carbidopa
Sponsor
University of Wisconsin, Madison